ETC
FOLD

Exchange Traded Concepts’s Amicus Therapeutics FOLD Stock Holding History

Exchange Traded Concepts’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,373
Closed -$260K – 1290
2023
Q3 		$260K Buy
21,373
+15,242
+249% +$197K 0.01% 758
2023
Q2 		$77K Buy
+6,131
New +$72.8K ﹤0.01% 984

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Exchange Traded Concepts's FOLD Position: Q4 2023 in Review

Exchange Traded Concepts sold out of Amicus Therapeutics (FOLD) in Q4 2023, closing a stake of 21,373 shares — an estimated $260K sold.

Exchange Traded Concepts first reported a position in FOLD in Q2 2023 and held it in 2 quarters. The position peaked at $260K in Q3 2023. 228 funds tracked by Wall St. Rank hold FOLD as of Q4 2023.

  • Exchange Traded Concepts reported no remaining Amicus Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 21,373 Amicus Therapeutics shares in Q4 2023, an estimated $260K.
  • Exchange Traded Concepts first reported a position in Amicus Therapeutics in Q2 2023 and held it in 2 quarters.
  • Exchange Traded Concepts's Amicus Therapeutics position peaked at $260K in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2023.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.